Skip to main content

Table 1 General characteristics of patients in a case–control study of post-dialysis fatigue

From: Association between corrected serum calcium levels after dialysis and post-dialysis fatigue risk: a hospital-based case–control study

Characteristic

Study patients (n = 610)

Fatigue (n = 340)

Non-Fatigue (n = 270)

P

Age, years

58 (47–66)

59 (49–67)

56 (46–64)

0.02

Male, n (%)

375 (61.48)

203 (59.71)

172 (63.70)

0.31

Time on dialysis, months

51(24–99)

50.5(25.5–101)

51.5 (23–95)

0.37

BMI (kg/m2)

23.5 (21–26.1)

23.80 (21.05–26.20)

23.20 (20.9–25.7)

0.17

Primary disease, n (%)

   

0.07

 Diabetic nephropathy

202 (33.11)

116 (34.12)

86 (31.85)

 

 Glomerulonephritis

239 (39.18)

127 (37.75)

112 (41.48)

 

 Hypertensive nephropathy

99 (16.23)

65 (19.12)

34 (12.59)

 

 Polycystic kidney

33 (5.41)

13 (3.82)

20 (7.41)

 

 Others

37 (6.07)

19 (5.59)

18 (6.67)

 

Residual renal function [yes, n (%)]

227 (37.21)

118 (34.71)

109 (40.37)

0.15

Hypertension [yes, n (%)]

453 (75.75)

250 (75.08)

203 (76.60)

0.66

Diabetes [yes, n (%)]

223 (37.29)

124 (37.24)

99 (37.36)

0.98

Daily exercise time n (%)

   

 < 0.01

 No

242 (39.67)

156 (45.88)

86 (31.85)

 < 0.01

 Less than 1 h

181 (29.67)

108 (31.76)

73 (27.04)

0.20

 1–2 h

123 (20.16)

50 (14.71)

73 (27.04)

 < 0.01

 Greater than 2 h

64 (10.49)

26 (7.65)

38 (14.07)

0.01

UFR, ml/kg∙h

   

0.74

  < 12.5

567 (92.95)

315 (92.65)

252 (93.33)

 

  ≥ 12.5

43 (7.05)

25 (7.35)

18 (6.67)

 

Hemoglobin, g/L

113 (102–122)

112.5 (100.5–122)

113 (104–121)

0.46

Albumin, g/L

41.9 (39.5–43.8)

41.5 (39.30–43.55)

42.2 (40–44)

0.01

Urea nitrogen, mmol/L

26.25 (22.65–30.03)

26.20 (22.75–30.11)

26.30 (22.40–30.01)

0.68

C-reactive protein, mg/L

3.14(3.14–7.71)

3.36 (3.14–7.74)

3.14 (3.14–7.62)

0.49

Phosphorus, mmol/L

1.99 (1.66–2.40)

1.99 (1.66–2.41)

1.99 (1.64–2.35)

0.68

Calcium, mmol/L

2.42 ± 0.12

2.43 ± 0.12

2.40 ± 0.13

 < 0.01

Single-pool Kt/Vurea

1.31 (1.17–1.47)

1.31 (1.17–1.47)

1.31 (1.18–1.47)

0.74

Pre-dialysis sodium, mmol/L

137.43 ± 3.41

137.34 ± 3.47

137.55 ± 3.35

0.44

Post-dialysis sodium, mmol/L

136.01 ± 2.29

136.07 ± 2.30

135.93 ± 2.28

0.46

Magnesium, mmol/L

1.09 (1.02–1.19)

1.10 (1.02–1.19)

1.09 (1.01–1.18)

0.57

iPTH, pg/mL

497.30 (278.10–803.90)

479.15 (274.45–804.75)

506.65 (280.80–797)

0.54

  1. BMI, body mass index; UFR, ultrafiltration rate; iPTH, intact Parathyroid Hormone
  2. Data are presented as means and standard deviations or medians [quartile 1, quartile 3] for continuous variables; and as frequencies and percentages for categorical variables
  3. P values were determined with one-way ANOVA tests or Mann–Whitney U tests for continuous variables and chi-square test for categorical variables
  4. All statistical tests are two sided